AU2008212556A1 - Visualization of biological material by the use of coated contrast agents - Google Patents

Visualization of biological material by the use of coated contrast agents Download PDF

Info

Publication number
AU2008212556A1
AU2008212556A1 AU2008212556A AU2008212556A AU2008212556A1 AU 2008212556 A1 AU2008212556 A1 AU 2008212556A1 AU 2008212556 A AU2008212556 A AU 2008212556A AU 2008212556 A AU2008212556 A AU 2008212556A AU 2008212556 A1 AU2008212556 A1 AU 2008212556A1
Authority
AU
Australia
Prior art keywords
group
silane
nanoparticles
composition
core particles
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2008212556A
Other languages
English (en)
Inventor
Oskar Axelsson
Kajsa Uvdal
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Spago Nanomedical AB
Original Assignee
SPAGO IMAGING AB
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by SPAGO IMAGING AB filed Critical SPAGO IMAGING AB
Publication of AU2008212556A1 publication Critical patent/AU2008212556A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/06—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
    • A61K49/18—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by a special physical form, e.g. emulsions, microcapsules, liposomes
    • A61K49/1818—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by a special physical form, e.g. emulsions, microcapsules, liposomes particles, e.g. uncoated or non-functionalised microparticles or nanoparticles
    • A61K49/1821—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by a special physical form, e.g. emulsions, microcapsules, liposomes particles, e.g. uncoated or non-functionalised microparticles or nanoparticles coated or functionalised microparticles or nanoparticles
    • A61K49/1824—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by a special physical form, e.g. emulsions, microcapsules, liposomes particles, e.g. uncoated or non-functionalised microparticles or nanoparticles coated or functionalised microparticles or nanoparticles coated or functionalised nanoparticles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/06—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
    • A61K49/18—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by a special physical form, e.g. emulsions, microcapsules, liposomes
    • A61K49/1818—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by a special physical form, e.g. emulsions, microcapsules, liposomes particles, e.g. uncoated or non-functionalised microparticles or nanoparticles
    • A61K49/1821—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by a special physical form, e.g. emulsions, microcapsules, liposomes particles, e.g. uncoated or non-functionalised microparticles or nanoparticles coated or functionalised microparticles or nanoparticles
    • A61K49/1824—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by a special physical form, e.g. emulsions, microcapsules, liposomes particles, e.g. uncoated or non-functionalised microparticles or nanoparticles coated or functionalised microparticles or nanoparticles coated or functionalised nanoparticles
    • A61K49/1827—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by a special physical form, e.g. emulsions, microcapsules, liposomes particles, e.g. uncoated or non-functionalised microparticles or nanoparticles coated or functionalised microparticles or nanoparticles coated or functionalised nanoparticles having a (super)(para)magnetic core, being a solid MRI-active material, e.g. magnetite, or composed of a plurality of MRI-active, organic agents, e.g. Gd-chelates, or nuclei, e.g. Eu3+, encapsulated or entrapped in the core of the coated or functionalised nanoparticle
    • A61K49/1833—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by a special physical form, e.g. emulsions, microcapsules, liposomes particles, e.g. uncoated or non-functionalised microparticles or nanoparticles coated or functionalised microparticles or nanoparticles coated or functionalised nanoparticles having a (super)(para)magnetic core, being a solid MRI-active material, e.g. magnetite, or composed of a plurality of MRI-active, organic agents, e.g. Gd-chelates, or nuclei, e.g. Eu3+, encapsulated or entrapped in the core of the coated or functionalised nanoparticle having a (super)(para)magnetic core coated or functionalised with a small organic molecule
    • A61K49/1848—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by a special physical form, e.g. emulsions, microcapsules, liposomes particles, e.g. uncoated or non-functionalised microparticles or nanoparticles coated or functionalised microparticles or nanoparticles coated or functionalised nanoparticles having a (super)(para)magnetic core, being a solid MRI-active material, e.g. magnetite, or composed of a plurality of MRI-active, organic agents, e.g. Gd-chelates, or nuclei, e.g. Eu3+, encapsulated or entrapped in the core of the coated or functionalised nanoparticle having a (super)(para)magnetic core coated or functionalised with a small organic molecule the small organic molecule being a silane
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/06—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
    • A61K49/18—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by a special physical form, e.g. emulsions, microcapsules, liposomes
    • A61K49/1818—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by a special physical form, e.g. emulsions, microcapsules, liposomes particles, e.g. uncoated or non-functionalised microparticles or nanoparticles
    • A61K49/1821—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by a special physical form, e.g. emulsions, microcapsules, liposomes particles, e.g. uncoated or non-functionalised microparticles or nanoparticles coated or functionalised microparticles or nanoparticles
    • A61K49/1824—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by a special physical form, e.g. emulsions, microcapsules, liposomes particles, e.g. uncoated or non-functionalised microparticles or nanoparticles coated or functionalised microparticles or nanoparticles coated or functionalised nanoparticles
    • A61K49/1827—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by a special physical form, e.g. emulsions, microcapsules, liposomes particles, e.g. uncoated or non-functionalised microparticles or nanoparticles coated or functionalised microparticles or nanoparticles coated or functionalised nanoparticles having a (super)(para)magnetic core, being a solid MRI-active material, e.g. magnetite, or composed of a plurality of MRI-active, organic agents, e.g. Gd-chelates, or nuclei, e.g. Eu3+, encapsulated or entrapped in the core of the coated or functionalised nanoparticle
    • A61K49/1851—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by a special physical form, e.g. emulsions, microcapsules, liposomes particles, e.g. uncoated or non-functionalised microparticles or nanoparticles coated or functionalised microparticles or nanoparticles coated or functionalised nanoparticles having a (super)(para)magnetic core, being a solid MRI-active material, e.g. magnetite, or composed of a plurality of MRI-active, organic agents, e.g. Gd-chelates, or nuclei, e.g. Eu3+, encapsulated or entrapped in the core of the coated or functionalised nanoparticle having a (super)(para)magnetic core coated or functionalised with an organic macromolecular compound, i.e. oligomeric, polymeric, dendrimeric organic molecule
    • A61K49/1857—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by a special physical form, e.g. emulsions, microcapsules, liposomes particles, e.g. uncoated or non-functionalised microparticles or nanoparticles coated or functionalised microparticles or nanoparticles coated or functionalised nanoparticles having a (super)(para)magnetic core, being a solid MRI-active material, e.g. magnetite, or composed of a plurality of MRI-active, organic agents, e.g. Gd-chelates, or nuclei, e.g. Eu3+, encapsulated or entrapped in the core of the coated or functionalised nanoparticle having a (super)(para)magnetic core coated or functionalised with an organic macromolecular compound, i.e. oligomeric, polymeric, dendrimeric organic molecule the organic macromolecular compound being obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. PLGA
    • A61K49/186—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by a special physical form, e.g. emulsions, microcapsules, liposomes particles, e.g. uncoated or non-functionalised microparticles or nanoparticles coated or functionalised microparticles or nanoparticles coated or functionalised nanoparticles having a (super)(para)magnetic core, being a solid MRI-active material, e.g. magnetite, or composed of a plurality of MRI-active, organic agents, e.g. Gd-chelates, or nuclei, e.g. Eu3+, encapsulated or entrapped in the core of the coated or functionalised nanoparticle having a (super)(para)magnetic core coated or functionalised with an organic macromolecular compound, i.e. oligomeric, polymeric, dendrimeric organic molecule the organic macromolecular compound being obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. PLGA the organic macromolecular compound being polyethyleneglycol [PEG]
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B82—NANOTECHNOLOGY
    • B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
    • B82Y5/00—Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery

Landscapes

  • Chemical & Material Sciences (AREA)
  • Nanotechnology (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Radiology & Medical Imaging (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biophysics (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Medical Informatics (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Magnetic Resonance Imaging Apparatus (AREA)
  • Medicinal Preparation (AREA)
AU2008212556A 2007-02-07 2008-01-10 Visualization of biological material by the use of coated contrast agents Abandoned AU2008212556A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US89999507P 2007-02-07 2007-02-07
US60/899,995 2007-02-07
PCT/IB2008/050084 WO2008096280A1 (en) 2007-02-07 2008-01-10 Visualization of biological material by the use of coated contrast agents

Publications (1)

Publication Number Publication Date
AU2008212556A1 true AU2008212556A1 (en) 2008-08-14

Family

ID=39321442

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2008212556A Abandoned AU2008212556A1 (en) 2007-02-07 2008-01-10 Visualization of biological material by the use of coated contrast agents

Country Status (8)

Country Link
US (2) US20100119458A1 (https=)
EP (2) EP2121041A1 (https=)
JP (1) JP2010518070A (https=)
CN (1) CN101663050A (https=)
AU (1) AU2008212556A1 (https=)
CA (1) CA2675631A1 (https=)
WO (2) WO2008096279A1 (https=)
ZA (1) ZA200905420B (https=)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8541006B2 (en) 2007-07-30 2013-09-24 University Of Maryland, Baltimore Methods and devices for the detection of biofilm
CN101790386B (zh) * 2007-08-31 2013-09-11 皇家飞利浦电子股份有限公司 用于磁性粒子成像的作为示踪物的群聚磁性粒子
EP2335073A4 (en) 2008-09-02 2012-09-26 Univ Maryland DIAGNOSIS OF BIOFILM IN VIVO INFECTION AND TREATMENT
US9399075B2 (en) 2008-12-29 2016-07-26 General Electric Company Nanoparticle contrast agents for diagnostic imaging
US8574549B2 (en) * 2008-12-29 2013-11-05 General Electric Company Nanoparticle contrast agents for diagnostic imaging
WO2011123030A1 (en) * 2010-03-30 2011-10-06 Spago Imaging Ab Nanoparticles comprising a core of amorphous rare earth element hydroxide and an organic coating
WO2012007567A1 (en) * 2010-07-16 2012-01-19 Technical University Of Denmark Nanoparticle-guided radiotherapy
KR20140011308A (ko) * 2010-12-08 2014-01-28 다우 코닝 도레이 캄파니 리미티드 금속 산화물 나노입자를 개질하는 방법
US9474810B2 (en) 2012-03-02 2016-10-25 General Electric Company Superparamagnetic nanoparticles with PEG substituted α-hydroxy phosphonate shells
CN104955486A (zh) * 2013-01-04 2015-09-30 延世大学校产学协力团 包含涂敷于纳米粒子载体表面的t1 造影物质的磁共振成像造影剂
EP2923712A1 (en) * 2014-03-28 2015-09-30 Spago Imaging AB Nanostructures and applications thereof
CN104021411B (zh) * 2014-05-30 2017-11-24 江苏多维科技有限公司 一种磁防伪标识及其识别系统
JP6471227B2 (ja) * 2014-09-15 2019-02-13 マサチューセッツ インスティテュート オブ テクノロジー 磁気共鳴画像法用途のためのナノ粒子
KR20170097510A (ko) 2016-02-18 2017-08-28 연세대학교 산학협력단 T1 mri 조영제로서의 나노입자의 분산 안정도를 증가시키는 방법 및 t1 mri 조영제 나노입자
WO2018154165A1 (es) * 2017-02-21 2018-08-30 Fundación Pública Andaluza Progreso Y Salud Nanopartículas modificadas con derivados alcoxi-silanos
WO2021144006A1 (en) 2020-01-14 2021-07-22 Seinberg Liis Metal-based core nanoparticles, synthesis and use
KR102379752B1 (ko) * 2020-08-19 2022-03-28 국민대학교산학협력단 X-선 감쇠 기반 생체 이미징용 나노입자 및 조성물
US20230355811A1 (en) * 2020-09-28 2023-11-09 University Of Florida Research Foundation, Inc. Compositions including magnetic nanoparticles and methods of using and making the same
CN112485283B (zh) * 2020-11-20 2024-05-17 中国农业科学院农产品加工研究所 基于细胞膜完整性变化的干燥技术评价方法

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4770183A (en) * 1986-07-03 1988-09-13 Advanced Magnetics Incorporated Biologically degradable superparamagnetic particles for use as nuclear magnetic resonance imaging agents
DE19612001A1 (de) * 1996-03-18 1997-09-25 Silica Gel Gmbh Adsorptions Te Superparamagnetische Teilchen mit vergrößerter R¶1¶-Relaxivität, Verfahren zur Herstellung und deren Verwendung
EP1368065B1 (de) * 2001-03-08 2007-06-27 Centrum für Angewandte Nanotechnologie (CAN) GmbH Paramagnetische nanopartikel
CN1231760C (zh) 2001-03-30 2005-12-14 清华大学 用于生物材料标记的稀土纳米粒子、其制备方法及用途
AU2003225901A1 (en) * 2002-03-19 2003-10-08 The Regents Of The University Of California Stabilized inorganic particles
FR2867180B1 (fr) 2004-03-02 2006-06-16 Univ Claude Bernard Lyon Nanoparticules hybrides comprenant un coeur de ln203 porteuses de ligands biologiques et leur procede de preparation
US20060014938A1 (en) * 2004-07-14 2006-01-19 Groman Ernest V Stable aqueous colloidal lanthanide oxides
US20080003184A1 (en) 2004-09-14 2008-01-03 Kajsa Uvdal Superparamagnetic Gadolinium Oxide Nanoscale Particles and Compositions Comprising Such Particles
US7462446B2 (en) * 2005-03-18 2008-12-09 University Of Washington Magnetic nanoparticle compositions and methods

Also Published As

Publication number Publication date
JP2010518070A (ja) 2010-05-27
WO2008096280A1 (en) 2008-08-14
WO2008096279A1 (en) 2008-08-14
EP2121041A1 (en) 2009-11-25
ZA200905420B (en) 2010-10-27
US20100119458A1 (en) 2010-05-13
CA2675631A1 (en) 2008-08-14
US20100111859A1 (en) 2010-05-06
CN101663050A (zh) 2010-03-03
EP2121040A1 (en) 2009-11-25

Similar Documents

Publication Publication Date Title
US20100111859A1 (en) Visualization of Biological Material by the Use of Coated Contrast Agents
US12533426B2 (en) Ultrafine nanoparticles comprising a functionalized polyorganosiloxane matrix and including metal complexes; method for obtaining same and uses thereof in medical imaging and/or therapy
EP2121038B1 (en) Tantalum oxide nanoparticles as imaging agents for x-ray/computed tomography and methods for making same
EP2379118B1 (en) Nanoparticle contrast agents for diagnostic imaging
US8728529B2 (en) Nanoparticle contrast agents for diagnostic imaging
Erogbogbo et al. Bioconjugation of luminescent silicon quantum dots to gadolinium ions for bioimaging applications
US20120201760A1 (en) Metal oxide particles coated with polyethylene glycol and their synthesis
US20060093555A1 (en) Imaging inflammatory conditions using superparamagnetic iron oxide agents
CN103638532B (zh) 一种氧化钆靶向磁共振造影剂
Cabrera-García et al. Engineered contrast agents in a single structure for T 1–T 2 dual magnetic resonance imaging
Yang et al. Synthesis of water well-dispersed PEGylated iron oxide nanoparticles for MR/optical lymph node imaging
KR101631311B1 (ko) 망간 이온이 도핑된 실리카 나노입자를 포함하는 ｍｒｉ 조영제
Li et al. Facile synthesis of manganese silicate nanoparticles for pH/GSH-responsive T 1-weighted magnetic resonance imaging
Cheng et al. Gadolinium-conjugated dendrimer nanoclusters as a tumor-targeted T1 magnetic resonance imaging contrast agent.
KR20070114943A (ko) 실리콘-포함 수용성 고분자로 코팅된 나노입자 및 그의조영제로서의 용도
US20060233713A1 (en) Gadolinium particle-based MRI contrast agents
Taylor Development of nanoscale metal-organic frameworks and hybrid silica nanoparticles for biomedical applications
Malenfant et al. Torres et al.(43) Pub. Date: May 4, 2006
Danafar New Insight about Biocompatibility and Biodegradability of Iron oxide Magnetic Nanoparticles: stereological and In VivoMRI Monitor

Legal Events

Date Code Title Description
MK1 Application lapsed section 142(2)(a) - no request for examination in relevant period